Pharmacology, Toxicology and Pharmaceutical Science
Acute Liver Failure
33%
Acute on Chronic Liver Failure
33%
Alanine Aminotransferase
18%
Albumin
11%
ANCA Associated Vasculitis
8%
Antiviral Drug
40%
Antivirus Agent
13%
Autoimmune Disease
24%
Bilirubin
16%
Chronic Hepatitis B
66%
Chronic Hepatitis C
50%
Combination Therapy
33%
Comorbidity
7%
Coronavirinae
16%
COVID-19 Vaccine
16%
Daclatasvir
35%
Disease Severity
11%
Diseases
82%
Entecavir
66%
Fibrosis
63%
Gastroesophageal Reflux
16%
Helicobacter Infection
14%
Helicobacter pylori
33%
Hepatic Encephalopathy
16%
Hepatitis B
20%
Hepatitis B Virus
50%
Hepatitis B(e) Antigen
66%
Hepatitis C
44%
Hepatitis C Virus
43%
Hyperlipidemia
7%
Hypotension
8%
Infection
96%
Inflammatory Bowel Disease
33%
Injection Pain
8%
Lactate Dehydrogenase
11%
Liver Cirrhosis
21%
Liver Disease
38%
Liver Fibrosis
33%
Maturity Onset Diabetes of the Young
35%
Non Erosive Reflux Disease
12%
Nonalcoholic Fatty Liver
100%
Observational Study
12%
Placebo
16%
Prevalence
51%
Ribavirin
35%
Side Effect
8%
Sofosbuvir
35%
Vasculitis
16%
Virus Hepatitis
9%
Virus RNA
20%
Medicine and Dentistry
Abdominal Examination
11%
Acute Liver Failure
14%
Acute on Chronic Liver Failure
14%
Anorexia
11%
Autoimmune Disease
16%
Awareness
16%
Bile Duct
16%
Cholangiocarcinoma
11%
Cholelithiasis
11%
Chronic Hepatitis B
33%
Chronic Hepatitis C
33%
Combination Therapy
16%
Computer Assisted Tomography
11%
COVID-19 Vaccine
16%
Diseases
36%
Electronic Health Record
13%
Endoscopic Retrograde Cholangiopancreatography
16%
Fatty Liver
33%
Fibrosis
36%
Gastrointestinal Perforation
16%
Gastrointestinal Stromal Tumor
33%
Health Care
16%
Hepatic Tuberculosis
33%
Hepatitis C Virus
16%
Hepatocellular Carcinoma
19%
Hepatomegaly
11%
Infection
22%
International Classification of Diseases
40%
Liver Biopsy
16%
Liver Disease
30%
Liver Failure
16%
Liver Fibrosis
16%
Liver Support
33%
Logistic Regression Analysis
12%
Magnetic Resonance Cholangiopancreatography
16%
Maturity Onset Diabetes of the Young
35%
Meta-Analysis
16%
Non Erosive Reflux Disease
12%
Non-Alcoholic Fatty Liver Disease
33%
Nonalcoholic Fatty Liver
72%
Nosology
33%
Pancreas Disease
16%
Pancreatic Duct
33%
Patient with Type 2 Diabetes
12%
Peginterferon
33%
Post-COVID-19
16%
Public Health
38%
Ribavirin
33%
Systematic Review
16%
Varices
33%
Nursing and Health Professions
Acute Liver Failure
16%
Acute on Chronic Liver Failure
16%
Body Mass
14%
Bone Density
33%
Bone Mass
33%
Cancer Growth Factor
5%
Chronic Hepatitis C
16%
Chronic Liver Disease
33%
Combination Therapy
16%
Construct Validity
11%
Cronbach Alpha Coefficient
22%
Cross-Sectional Study
11%
Diseases
10%
Esophagus Varices
5%
Exploratory Factor Analysis
11%
Fatty Liver
33%
Hepatic Encephalopathy
8%
Hepatitis C
11%
Hospital Setting
11%
Infection
18%
Internal Consistency
33%
Liver Biopsy
9%
Liver Cell Carcinoma
33%
Liver Cirrhosis
8%
Liver Disease
5%
Liver Failure
33%
Liver Fibrosis
33%
Liver Support
33%
MAFLD
9%
Maturity Onset Diabetes of the Young
16%
Meta Analysis
16%
Molecular Pathology
5%
Morbid Obesity
5%
Nonalcoholic Fatty Liver
17%
Osteopenia
8%
Patient with Inflammatory Bowel Disease
33%
Peginterferon
33%
Platelet Count
7%
Prevalence
7%
Ribavirin
33%
Scar Formation
5%
Sustained Virologic Response
33%
Systematic Review
16%
Ulcerative Colitis
8%
University Hospital
12%
Varicosis
33%
Virus Hepatitis
9%
Virus Load
6%
